Selank 10mg

Quickstart Highlights

Selank is a synthetic heptapeptide analog of tuftsin with demonstrated anxiolytic and anti-asthenic (energy-boosting) properties in human clinical trials[1][2]. In Russian studies, intranasal Selank produced anxiolytic effects comparable to benzodiazepines without sedation or dependence potential[1]. This educational protocol presents a once‑daily subcutaneous approach using practical dilution for accurate insulin‑syringe measurements.

Reconstitute: Add 3.0 mL bacteriostatic water (max vial capacity) → ~3.33 mg/mL concentration.
Typical daily range: 300–500 mcg once daily subcutaneously (gradual titration).
Easy measuring: At 3.33 mg/mL, 1 unit = 0.01 mL ≈ 33.3 mcg on a U‑100 insulin syringe.
Storage: Lyophilized: freeze at −20 °C (−4 °F); after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F); avoid freeze–thaw cycles.

Dosing & Reconstitution Guide

Educational guide for reconstitution and weekly dosing

Standard / Gradual Approach (3 mL = ~3.33 mg/mL)

Week	Daily Dose (mcg)	Units (per injection) (mL)
Weeks 1–2	300 mcg (0.3 mg)	9 units (0.09 mL)
Weeks 3–4	500 mcg (0.5 mg)	15 units (0.15 mL)

Frequency: Inject once daily subcutaneously[3]. A common cycling pattern is 4 weeks on, 4 weeks off to prevent tachyphylaxis, though continuous daily use has been studied in clinical trials for up to 14 days with good tolerability[2]. Some practitioners recommend administering 5 days per week with 2-day breaks[3].
For ≤10‑unit (≤0.10 mL) administrations, consider 30‑ or 50‑unit insulin syringes for improved readability.

Reconstitution Steps

Reference-derived details for Selank 10mg.

Draw 3.0 mL bacteriostatic water with a sterile syringe.
Inject slowly down the vial wall; avoid foaming.
Gently swirl/roll until dissolved (do not shake vigorously as peptides are delicate).
Label and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light.

Supplies Needed

Plan based on an 8–16 week protocol with 4-week cycles and gradual titration.

Peptide Vials (Selank, 10 mg each):
Peptide Vials (Selank, 10 mg each):: 8 weeks (one 4-week cycle) ≈ 2 vials
Peptide Vials (Selank, 10 mg each):: 12 weeks (1.5 cycles) ≈ 4 vials
Peptide Vials (Selank, 10 mg each):: 16 weeks (two complete cycles) ≈ 5 vials
Insulin Syringes (U‑100):
Insulin Syringes (U‑100):: Per week: 7 syringes (1/day)
Insulin Syringes (U‑100):: 8 weeks: 56 syringes
Insulin Syringes (U‑100):: 12 weeks: 84 syringes
Insulin Syringes (U‑100):: 16 weeks: 112 syringes
Bacteriostatic Water (10 mL bottles): Use ~3.0 mL per vial for reconstitution.
Bacteriostatic Water (10 mL bottles): Use ~3.0 mL per vial for reconstitution.: 8 weeks (2 vials): 6 mL → 1 × 10 mL bottle
Bacteriostatic Water (10 mL bottles): Use ~3.0 mL per vial for reconstitution.: 12 weeks (4 vials): 12 mL → 2 × 10 mL bottles
Bacteriostatic Water (10 mL bottles): Use ~3.0 mL per vial for reconstitution.: 16 weeks (5 vials): 15 mL → 2 × 10 mL bottles
Alcohol Swabs: One for the vial stopper + one for the injection site each day.
Alcohol Swabs: One for the vial stopper + one for the injection site each day.: Per week: 14 swabs (2/day)
Alcohol Swabs: One for the vial stopper + one for the injection site each day.: 8 weeks: 112 swabs → recommend 2 × 100‑count boxes
Alcohol Swabs: One for the vial stopper + one for the injection site each day.: 12 weeks: 168 swabs → recommend 2 × 100‑count boxes
Alcohol Swabs: One for the vial stopper + one for the injection site each day.: 16 weeks: 224 swabs → recommend 3 × 100‑count boxes

Protocol Overview

Concise summary of the once‑daily anxiolytic/nootropic regimen.

Goal: Support reduction of anxiety and neurasthenia symptoms while providing anti-asthenic (energy-boosting) benefits[1][2]. Open source
Schedule: Daily subcutaneous injections for 4-week cycles with 4-week breaks (8–16 weeks total protocol).
Dose Range: 300–500 mcg daily with gradual titration.
Reconstitution: 3.0 mL per 10 mg vial (~3.33 mg/mL) for accurate unit measurements.
Storage: Lyophilized frozen; reconstituted refrigerated; avoid repeated freeze–thaw.

Dosing Protocol

Suggested daily titration approach.

Start: 300 mcg daily for weeks 1–2; clinicians treating cognitive or anxiety issues often begin at this level[3]. Open source
Target: 500 mcg daily by weeks 3–4 if lower doses are well-tolerated.
Frequency: Once per day (subcutaneous); some protocols use 5 days per week with 2-day breaks[3]. Open source
Cycle Pattern: 4 weeks on, 4 weeks off to prevent tachyphylaxis; repeat as needed.
Timing: Any consistent time; rotate injection sites to prevent irritation.

Storage Instructions

Proper storage preserves peptide quality.

Lyophilized: Store at −20 °C (−4 °F) for long-term stability (several months); refrigeration at 2–8 °C (35.6–46.4 °F) acceptable for shorter periods[10]. Open source
Reconstituted: Refrigerate at 2–8 °C (35.6–46.4 °F); stable for approximately 1 month with minimal potency loss[10]. Prepare aliquots if needed and avoid freeze–thaw cycles. Open source
Allow vials to reach room temperature before opening to reduce condensation and moisture uptake.

Important Notes

Practical considerations for consistency and safety.

Use new sterile insulin syringes for each injection; dispose in a sharps container immediately after use[9]. Open source
Rotate injection sites (abdomen, thighs, upper arms) systematically to reduce local irritation and prevent tissue changes[7]. Open source
Inject slowly and steadily; wait a few seconds before withdrawing the needle.
Document daily dose, timing, and site rotation to maintain consistency throughout the protocol.
Multi-use bacteriostatic water vials should be dated upon opening and discarded within 28 days[9]. Open source

How This Works

Selank is a synthetic analog of the immunomodulatory peptide tuftsin, consisting of the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro. In Russian clinical trials for anxiety disorders and neurasthenia, intranasal Selank produced anxiolytic effects comparable to benzodiazepines while also providing anti-asthenic (energy-boosting) benefits without sedative side effects or dependence potential[1][2]. Preclinical studies in primates demonstrated that intranasal Selank eliminated fear and anxiety behaviors with long-term stabilizing effects on neurobehavior[4]. Rodent studies confirmed robust anxiolytic efficacy comparable to classical tranquilizers[5]. While most published human data utilized intranasal dosing (the original formulation), subcutaneous administration has shown effectiveness in research settings with consistent absorption and ease of dose measurement[3].

Lifestyle Factors

Complementary strategies for optimal cognitive and anxiolytic outcomes.

Maintain consistent sleep hygiene and aim for 7–9 hours of quality sleep to support neurological function and stress resilience.
Incorporate regular physical activity; both aerobic exercise and resistance training support mood regulation and cognitive performance.
Practice stress-management techniques such as mindfulness, meditation, or breathwork to complement Selank’s anxiolytic effects.
Support nutritional status with adequate protein, omega-3 fatty acids, and micronutrients essential for neurotransmitter synthesis.
Minimize alcohol and stimulant use, which can interfere with anxiety management and neurological stability.

Potential Benefits & Side Effects

Observations from clinical and preclinical literature.

Produces anxiolytic effects comparable to benzodiazepines in human clinical trials without sedation or dependence risk[1]. Open source
Provides anti-asthenic (energy-boosting) benefits alongside anxiety reduction[2]. Open source
Induces lasting neurobehavioral changes; primate studies showed elimination of fear/anxiety behaviors with long-term stabilizing effects[4]. Open source
Generally well tolerated in clinical studies; a 14-day continuous course was well-tolerated and effective in human trials[2]. Open source
Occasional mild injection-site reactions (redness, minor irritation) may occur with subcutaneous administration; proper site rotation minimizes this risk.
Lacks sedative side effects typical of classical anxiolytics, allowing for daytime use without impairment[1]. Open source
Has been explored at higher doses for experimental applications such as attenuating opioid withdrawal symptoms, indicating a wide therapeutic range[5]. Open source

Injection Technique

General subcutaneous guidance from clinical best-practice resources[7][8].

Wash hands thoroughly and prepare a clean work surface.
Clean the vial stopper with an alcohol swab; allow to dry completely.
Draw the appropriate volume into a sterile insulin syringe; remove air bubbles by flicking the syringe and expelling air.
Clean the injection site with a fresh alcohol swab; allow skin to dry to prevent stinging.
Pinch a skinfold of subcutaneous tissue; insert the needle at 90° into the subcutaneous layer[7]. Open source
Do not aspirate for subcutaneous injections; inject slowly and steadily[8]. Open source
Withdraw the needle straight out after injection; apply gentle pressure if minor bleeding occurs.
Dispose of the used syringe immediately in an appropriate sharps container; never reuse needles or syringes[9]. Open source
Rotate sites systematically (abdomen at least 2 inches from navel, front/outer thighs, upper arms) to avoid lipohypertrophy[7]. Open source

Recommended Source

We recommend Prime Lab Peptides for high‑purity Selank (10 mg).

High‑purity, third‑party‑tested lots with batch Certificates of Analysis (COAs).
Consistent, ISO‑aligned handling and comprehensive documentation.
Reliable fulfillment with proper cold‑chain management to maintain peptide integrity.
Transparent sourcing and quality control procedures for research-grade peptides.

Important Note

This page is informational and does not authorize use. Peptify clients should complete assessment, disclose medications and health history, and follow the clinician-approved plan only.

Do not start, stop, combine, or change a protocol based only on website content.
Emergency symptoms require urgent medical care, not a website or routine follow-up message.

References